We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.19B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
AUM
$2.1B
AUM Growth
-$82.5M
Cap. Flow
+$270K
Cap. Flow %
0.01%
Top 10 Hldgs %
59.17%
Holding
32
New
5
Increased
8
Reduced
16
Closed
3

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$70.4M
2
KO icon
Coca-Cola
KO
+$55.8M
3
UBER icon
Uber
UBER
+$53.2M
4
MDT icon
Medtronic
MDT
+$43.2M
5
PEP icon
PepsiCo
PEP
+$40.4M

Top Sells

Rank Stock Value
1
KT icon
KT
KT
+$101M
2
QCOM icon
Qualcomm
QCOM
+$68.8M
3
BIDU icon
Baidu
BIDU
+$46.1M
4
EFX icon
Equifax
EFX
+$33.1M
5
B
Barrick Mining
B
+$31.5M

Sector Composition

Rank Sector Weight
1 Technology 22.49%
2 Consumer Discretionary 21.48%
3 Healthcare 15.85%
4 Industrials 14.6%
5 Financials 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$170M 8.12%
1,223,595
-70,790
-5% -$9.73M
BABA icon
2
Alibaba
BABA
$279B
$149M 7.11%
890,846
+409,601
+85% +$70.4M
MRK icon
3
Merck
MRK
$321B
$149M 7.1%
1,853,247
+317,954
+21% +$25.5M
CSCO icon
4
Cisco
CSCO
$448B
$134M 6.39%
2,709,079
-30,782
-1% -$1.6M
YUMC icon
5
Yum China
YUMC
$15.9B
$117M 5.57%
2,569,525
-240,183
-9% -$10.7M
GILD icon
6
Gilead Sciences
GILD
$163B
$116M 5.52%
1,824,290
-49,715
-3% -$3.25M
GE icon
7
GE Aerospace
GE
$368B
$111M 5.29%
2,490,376
-469,650
-16% -$22.1M
FTI icon
8
TechnipFMC
FTI
$27.5B
$102M 4.88%
5,696,863
+791,719
+16% +$14.8M
COF icon
9
Capital One
COF
$129B
$97.5M 4.65%
1,071,375
+110,795
+12% +$9.96M
FDX icon
10
FedEx
FDX
$73B
$95.5M 4.56%
655,953
+138,529
+27% +$22.3M
EXPE icon
11
Expedia Group
EXPE
$35.2B
$92.3M 4.4%
686,488
-179,757
-21% -$23.8M
TPR icon
12
Tapestry
TPR
$30.8B
$92M 4.39%
3,529,763
-867,360
-20% -$22.9M
B
13
Barrick Mining
B
$63.2B
$90.3M 4.31%
5,211,696
-1,784,712
-26% -$31.5M
QCOM icon
14
Qualcomm
QCOM
$160B
$82.2M 3.92%
1,077,647
-914,758
-46% -$68.8M
MDT icon
15
Medtronic
MDT
$110B
$67.8M 3.24%
624,368
+414,448
+197% +$43.2M
EFX icon
16
Equifax
EFX
$20.7B
$66.2M 3.16%
470,433
-234,621
-33% -$33.1M
TIF
17
DELISTED
Tiffany & Co.
TIF
$64M 3.05%
691,282
+281,928
+69% +$25.4M
META icon
18
Meta Platforms (Facebook)
META
$1.37T
$64M 3.05%
359,249
+42,562
+13% +$8.09M
KO icon
19
Coca-Cola
KO
$381B
$56.7M 2.7%
+1,041,328
New +$55.8M
UBER icon
20
Uber
UBER
$143B
$43.1M 2.06%
+1,414,018
New +$53.2M
STX icon
21
Seagate
STX
$193B
$42.3M 2.02%
+786,221
New +$38.6M
PEP icon
22
PepsiCo
PEP
$191B
$41.7M 1.99%
+304,230
New +$40.4M
OC icon
23
Owens Corning
OC
$11.2B
$33.4M 1.59%
527,760
-82,441
-14% -$4.72M
CEF icon
24
Sprott Physical Gold and Silver Trust
CEF
$7.56B
$13.1M 0.63%
925,055
-800,432
-46% -$11.4M
IBN icon
25
ICICI Bank
IBN
$109B
$6.11M 0.29%
501,467
-158,938
-24% -$1.86M

Similar funds

Antipodes Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Antipodes Partners held 32 positions worth $2.1B, down 3.8% from $2.18B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Antipodes Partners's Q3 2019 filing shows 5 new, 8 increased, 16 reduced and 3 closed positions. Its largest new stake was Coca-Cola: 1,041,328 shares worth $56.7M. The largest sale was KT, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Antipodes Partners's largest Q3 2019 buy was Coca-Cola: 1,041,328 shares worth $56.7M.
  • Antipodes Partners added most to Alibaba in Q3 2019, an estimated $70.4M increase.
  • Antipodes Partners's biggest Q3 2019 reduction was KT, cutting an estimated $101M.
  • Antipodes Partners fully exited KB Financial Group in Q3 2019, selling an estimated $7.97M.
  • Antipodes Partners's ten largest holdings make up 59% of its $2.1B portfolio in Q3 2019.
  • Antipodes Partners opened 5 new positions and closed 3 in Q3 2019.
  • Antipodes Partners's portfolio value fell 3.8% quarter-over-quarter to $2.1B.

Based on Antipodes Partners's 13F filing for Q3 2019, filed 6 Nov 2019.